Brain Aging: Protecting Cognitive Function Over Time

What Changes in the Aging Brain

Normal cognitive aging is not uniform. Some functions decline reliably and others hold or improve.

Declines with age: processing speed, which begins falling in early adulthood and underlies much of what feels like memory decline; working memory capacity; divided attention; episodic memory retrieval, particularly free recall as opposed to recognition; and executive flexibility.

Preserved or improved: vocabulary and semantic knowledge, which typically peak late; crystallised expertise in familiar domains; emotional regulation, which improves on average; and pattern recognition within a domain of experience.

Structurally, synaptic density declines more than neuronal number in most regions, which is important because synapses are considerably more plastic than neurons. White matter integrity declines, particularly in prefrontal tracts, slowing signal transmission. Cerebral blood flow falls, and small vessel changes accumulate, which is where the overlap with cardiovascular health becomes decisive. Glymphatic clearance, most active during deep sleep, becomes less effective, reducing the removal of metabolic byproducts including amyloid beta and tau.

The Modifiable Factors

Major evidence reviews have converged on a list of modifiable contributors accounting for a substantial fraction of dementia cases at population level. The list is worth reading carefully, because several items are routinely absent from optimisation discussion.

• Hearing loss in midlife. One of the largest single contributors identified, and hearing aid use in those with hearing loss is associated with lower cognitive decline in trial and cohort data. This is a cheap, specific and widely ignored intervention.
• Hypertension in midlife. Blood pressure control in the forties and fifties has more cognitive consequence than in later decades.
• Physical inactivity. Associated with hippocampal volume and executive function, with exercise interventions showing modest cognitive effects.
• Smoking. Vascular and inflammatory routes.
• Impaired glucose handling and obesity. Insulin resistance affects cerebral glucose metabolism and small vessel integrity.
• Depression. Bidirectional relationship, and addressing it matters regardless of direction.
• Social isolation. Consistently associated, with effect sizes that surprise people.
• Low educational attainment and low cognitive engagement. Related to cognitive reserve, discussed below.
• Excess alcohol. Dose-related, with heavy intake clearly harmful and the status of light intake genuinely uncertain.
• Head injury. Including repeated subconcussive impact.
• Air pollution. Increasingly well supported, and largely addressed through environment rather than behaviour.
• Visual impairment. Added in more recent reviews, on similar reasoning to hearing.

Notice that almost none of these are brain-specific. The brain is the organ most sensitive to vascular, metabolic and sensory conditions elsewhere, which is why cognitive protection is largely achieved by not being a cardiovascular or metabolic problem.

Cognitive Reserve

Cognitive reserve describes the observation that people with similar levels of measurable brain damage can differ substantially in cognitive function. Some brains tolerate more damage before function declines.

Reserve appears to be built through education, occupational complexity, cognitive engagement, bilingualism and social network richness, and it does not prevent damage accumulating. It changes the threshold at which accumulated damage produces symptoms, which is a different and still valuable mechanism.

The practical implication is nuanced. Novel, effortful and socially embedded cognitive activity has better support than repetitive brain-training exercises, whose benefits tend to be specific to the trained task and to transfer poorly. Learning an instrument, a language or a genuinely new skill involves difficulty, feedback and often social interaction, which is a plausible reason it appears more effective than a puzzle application.

Sleep and the Glymphatic Argument

The glymphatic system, a perivascular clearance route that moves cerebrospinal fluid through brain tissue, is substantially more active during sleep, particularly slow wave sleep. It clears metabolic byproducts including amyloid beta and tau.

Controlled sleep deprivation in humans increases amyloid beta in cerebrospinal fluid measurably after a single night. Longitudinal cohort data associate short sleep in midlife with later dementia incidence. Obstructive sleep apnoea associates with cognitive outcomes independently of other factors.

This makes sleep one of the highest-leverage cognitive interventions available, and it is generally regarded as a lifestyle preference rather than as a neurological one. The specific components that matter are duration, slow wave sleep, which loads the first half of the night, and the absence of unaddressed sleep-disordered breathing.

What the Supplement Evidence Supports

Honestly: less than the market implies.

• Omega-3, DHA-weighted. Observational association between higher DHA status and slower cognitive decline is consistent. Intervention trials in cognitively healthy adults are mixed to null over typical durations. Plausible, unproven.
• B vitamins, where homocysteine is elevated. Lowering homocysteine with folate, B12 and B6 has shown cognitive benefit in trials restricted to participants with elevated homocysteine, and null results in unselected populations. A good example of why the population matters more than the compound.
• Creatine. Emerging evidence for cognitive effects, particularly under sleep deprivation or in vegetarians with lower baseline stores.
• Lion's mane. One controlled trial in mild cognitive impairment with a positive result that reversed after withdrawal. Small, promising, not established.
• Citicoline, bacopa, ginkgo. Small trials with mixed results. Bacopa has the more consistent memory findings over eight to twelve weeks.
• Vitamin D, where status is low. Association is clear, intervention evidence is weak.
• Multivitamin. Interestingly, several recent randomised trials in older adults reported modest cognitive benefits from a daily multivitamin, which is a more surprising and better-controlled result than most single-compound work.

None of these approaches the effect size of addressing hearing loss, midlife blood pressure, sleep apnoea or physical inactivity. That is the ordering the evidence supports.

Tracking Cognitive Function Honestly

Self-assessment of cognition is unreliable, because perceived clarity tracks sleep, mood, caffeine and stress far more than it tracks underlying function. Objective measures are the only way to detect a real trend.

Usable measures: validated computerised cognitive batteries repeated under standard conditions, which are available to consumers and reasonably sensitive for processing speed and working memory; simple reaction time, which is a good proxy for processing speed and can be measured consistently; and paper-based screening tools administered clinically for a formal baseline.

Conditions matter enormously. Test at the same time of day, similar sleep state, similar caffeine intake, and not while unwell. Cognitive test variability from state factors easily exceeds a year of aging effect.

Practice effects. Repeated testing improves scores independently of function, which is one reason single before-and-after comparisons in supplement trials are unreliable and why proper trials use control groups.

What to do with a concerning result. A single poor result is weak evidence. A consistent decline across repeated standardised testing, or subjective decline noticed by family rather than self, is a reason for clinical assessment, where reversible contributors including thyroid status, B12 status, medication effects, sleep-disordered breathing, depression and hearing loss can be identified.